Self-assembling peptide and peptide gel with high strength
Abstract
Provide are a peptide gel with practically sufficient mechanical strength and a self-assembling peptide capable of forming the peptide gel. The self-assembling peptide is formed of the following amino acid sequence: a 1 b 1 c 1 b 2 a 2 b 3 db 4 a 3 b 5 c 2 b 6 a 4 where: a 1 to a 4 each represent a basic amino acid residue; b 1 to b 6 each represent an uncharged polar amino acid residue and/or a hydrophobic amino acid residue, provided that at least five thereof each represent a hydrophobic amino acid residue; c 1 and c 2 each represent an acidic amino acid residue; and d represents a hydrophobic amino acid residue.
Claims
exact text as granted — not AI-modified1 . A self-assembling peptide, comprising an amino acid sequence:
a 1 b 1 c 1 b 2 a 2 b 3 db 4 a 3 b 5 c 2 b 6 a 4 , wherein a 1 to a 4 each represent a basic amino acid residue, b 1 to b 6 each represent at least one selected from the group consisting of an uncharged polar amino acid residue and a hydrophobic amino acid residue, provided that at least five thereof each represent a hydrophobic amino acid residue, c 1 and c 2 each represent an acidic amino acid residue, and d represents a hydrophobic amino acid residue.
2 . The peptide of claim 1 , wherein b 3 and b 4 in the amino acid sequence each represent a hydrophobic amino acid residue.
3 . The peptide of claim 1 , wherein all of b 1 to b 6 in the amino acid sequence each represent a hydrophobic amino acid residue.
4 . The peptide according claim 1 , wherein b 1 to b 6 in the amino acid sequence each independently represent an alanine residue, a valine residue, a leucine residue, or an isoleucine residue.
5 . The peptide according claim 1 , wherein d in the amino acid sequence represents an alanine residue, a valine residue, a leucine residue, or an isoleucine residue.
6 . The peptide according claim 1 , wherein the self-assembling peptide comprises a peptide formed of an amino acid sequence of RLDLRLALRLDLR (SEQ ID NO: 1), RLDLRLLLRLDLR (SEQ ID NO: 2), RADLRLALRLDLR (SEQ ID NO: 6), RLDLRLALRLDAR (SEQ ID NO: 7), RADLRLLLRLDLR (SEQ ID NO: 8), RADLRLLLRLDAR (SEQ ID NO: 9), RLDLRALLRLDLR (SEQ ID NO: 10), or RLDLRLLARLDLR (SEQ ID NO: 11).
7 . The peptide according claim 1 , wherein the self-assembling peptide comprises a peptide formed of an amino acid sequence of RLDLRLALRLDLR(SEQ ID NO: 1) or RLDLRLLLRLDLR(SEQ ID NO: 2).
8 . A modified peptide, comprising the peptide according to claim 1 ,
wherein at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group is modified, and wherein the modified peptide has a self-assembling ability.
9 . The modified peptide according to claim 8 , wherein the at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group has added thereto an amino acid sequence comprising RGD.
10 . A peptide gel, which is formed from an aqueous solution comprising at least one selected from the group consisting of:
the peptide according to claim 1 and a modified peptide comprising: the peptide of claim 1 , wherein at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group is modified, and wherein the modified peptide has a self-assembling ability.
11 . The peptide gel according to claim 10 , wherein the aqueous solution further comprises an additive.
12 . The peptide gel according to claim 11 , wherein the additive comprises at least one selected from the group consisting of a pH adjuster, an amino acid, a vitamin, a saccharide, a polysaccharide, an alcohol, a polyalcohol, a pigment, a bioactive substance, an enzyme, an antibody, DNA, and RNA.
13 . The peptide gel according to claim 10 , wherein the peptide gel has an absolute value L (g/s) of an amount of change in load per unit time of 0.03 g/s or more in an approximate straight line of values measured from a start of compression to between 8 and 10 seconds in a compression test carried out at a compression speed of 0.05 mm/s with a jig whose tip has a spherical shape with a diameter of 3.2 mm and a curvature radius of 1.6 mm under a temperature condition of 22° C.
14 . A substrate, comprising at least one selected from the group consisting of:
(i) the peptide according to claim 1 , (ii) a modified peptide, comprising the peptide of claim 1 , wherein at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group is modified, and wherein the modified peptide has a self-assembling ability; (iii) a peptide gel, which is formed from an aqueous solution comprising at least one selected from the group consisting of:
the peptide of claim 1 ; and
a modified peptide, comprising the peptide of claim 1 , wherein at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group is modified, and wherein the modified peptide has a self-assembling ability,
wherein the substrate is suitable for a cell culture.
15 . A method for manufacturing a sterile peptide, comprising:
sterilizing at least one selected from the group consisting of the peptide according to claim 1 and a modified peptide comprising the peptide of claim 1 , wherein at least one selected from the group consisting of the N-terminal amino group and the C-terminal carboxyl group is modified, and wherein the modified peptide has a self-assembling ability, under a pressurized condition at 100° C. or more.
16 . A method for manufacturing an article coated with a peptide gel, comprising:
freezing the peptide gel according to claim 10 , to obtain a frozen peptide gel; melting the frozen peptide gel to provide a peptide sol; coating at least part of a surface of an article with the peptide sol; and reconstructing a peptide gel from the peptide sol.
17 . The peptide of claim 2 , wherein all of b 1 to b 6 in the amino acid sequence each represent a hydrophobic amino acid residue.
18 . The peptide of claim 2 , wherein b 1 to b 6 in the amino acid sequence each independently represent an alanine residue, a valine residue, a leucine residue, or an isoleucine residue.
19 . The peptide of claim 3 , wherein b 1 to b 6 in the amino acid sequence each independently represent an alanine residue, a valine residue, a leucine residue, or an isoleucine residue.
20 . The peptide of claim 2 , wherein d in the amino acid sequence represents an alanine residue, a valine residue, a leucine residue, or an isoleucine residue.Join the waitlist — get patent alerts
Track US2015125611A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.